Archive: 2026/03

Pitavastatin and Diabetes Risk: What You Need to Know About Its Metabolic Effects

Pitavastatin lowers cholesterol with less impact on blood sugar than other statins. Learn why it's a preferred option for people with prediabetes or metabolic syndrome - and how it compares to atorvastatin and rosuvastatin.

20.03.26
Alistair Mukondiwa
2

Kidney Disease Medications: Phosphate Binders, Diuretics, and Anticoagulants Explained

Phosphate binders, diuretics, and anticoagulants are essential for managing kidney disease complications. Learn how they work, their real-world costs, side effects, and what experts recommend for better outcomes.

19.03.26
Alistair Mukondiwa
3

OTC Constipation Remedies: Fiber, Stool Softeners, and Laxatives Explained

Learn how fiber, stool softeners, and laxatives like MiraLax and Dulcolax work for constipation. Discover which OTC remedies are most effective, safest for long-term use, and how to avoid common mistakes.

17.03.26
Alistair Mukondiwa
5

Heart Medications and Their Dangerous Combinations: What to Avoid

Heart medications can be deadly when mixed with common drugs like ibuprofen, NSAIDs, or supplements. Learn the seven most dangerous combinations, why OTC meds are risky, and how to protect yourself from life-threatening interactions.

13.03.26
Alistair Mukondiwa
11

Prescription Label Layouts: Why Your Medication Bottle Looks Different

Prescription labels in the U.S. vary by state, pharmacy, and software system - creating confusion and risking medication errors. Learn why your bottle looks different and how to stay safe.

12.03.26
Alistair Mukondiwa
11

Import Alerts: How the FDA Blocks Drugs from Non-Compliant Manufacturers

The FDA uses Import Alerts to block drugs from non-compliant manufacturers before they reach U.S. patients. Learn how the Green List system works, why shipments get detained, and what it means for global drug supply chains.

10.03.26
Alistair Mukondiwa
11

European Generic Markets: How Regulatory Approaches Across the EU Shape Drug Access and Competition

The EU's generic drug approval system is complex, with four different pathways, each affecting how quickly and where a generic reaches patients. The 2025 reforms have changed data protection, launch timelines, and supply rules-shifting how manufacturers enter the market.

6.03.26
Alistair Mukondiwa
12

How to Communicate Past Drug Reactions Before Surgery

Knowing how to clearly communicate past drug reactions before surgery can prevent life-threatening complications. Learn what counts as a true allergy, who needs to know, and how to ensure your history is properly documented for safe anesthesia.

5.03.26
Alistair Mukondiwa
13

Obesity as a Chronic Disease: Understanding Metabolic Health and Realistic Weight Strategies

Obesity is a chronic disease driven by biology, not choice. Learn how metabolic dysfunction, genetics, and modern treatments like GLP-1 agonists are changing how we manage weight - and why willpower alone doesn't work.

3.03.26
Alistair Mukondiwa
0

From ANDA to Shelf: How Generic Drugs Reach Retail Pharmacies
21 Dec 2025
RSV Infections: Risks for Infants, Older Adults, and How to Prevent Them
24 Feb 2026
Switching from Brand to Authorized Generic: Practical Tips for Patients and Pharmacies
20 Nov 2025
Carbimazole and Fertility: What You Should Know
19 May 2023
The Role of Diet and Nutrition in Managing Sickle Cell Anemia
12 May 2023